Related Experiment Video
Updated: Mar 26, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell
Jing Wen1,2, Jianhua Fu2,3, Yihong Ling2,4
1Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abstract:
The migration and invasion inhibitory protein (MIIP) has been discovered recently to have inhibitory functions in cell proliferation and migration. Overexpression of MIIP reduced the intracellular steady-state level of epidermal growth factor receptor (EGFR) protein in lung cancer cells with no effect on EGFR mRNA expression compared to that in the control cells. This MIIP-promoted EGFR protein degradation was reversed by proteasome and lysosome inhibitors, suggesting the involvement of both proteasomal and lysosomal pathways in this degradation. This finding was further validated by pulse-chase experiments using 35S-methionine metabolic labeling. We found that MIIP accelerates EGFR protein turnover via proteasomal degradation in the endoplasmic reticulum and then via the lysosomal pathway after its entry into endocytic trafficking. MIIP-stimulated downregulation of EGFR inhibits downstream activation of Ras and blocks the MEK signal transduction pathway, resulting in inhibition of cell proliferation. The negative correlation between MIIP and EGFR protein expression was validated in lung adenocarcinoma samples. Furthermore, the higher MIIP protein expression predicts a better overall survival of Stage IA-IIIA lung adenocarcinoma patients who underwent radical surgery. These findings reveal a new mechanism by which MIIP inhibits cell proliferation.
Insights
Migration and invasion inhibitory protein (MIIP) reduces epidermal growth factor receptor (EGFR) protein levels in lung cancer cells, inhibiting proliferation. Higher MIIP expression correlates with better survival in lung adenocarcinoma patients.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The migration and invasion inhibitory protein (MIIP) is a recently identified protein with roles in inhibiting cell proliferation and migration.
- Epidermal growth factor receptor (EGFR) is a key regulator of cell growth and is often dysregulated in cancer.
Purpose of the Study:
- To elucidate the mechanism by which MIIP inhibits cell proliferation.
- To investigate the relationship between MIIP and EGFR in lung cancer.
Main Methods:
- Overexpression of MIIP in lung cancer cells.
- Assessment of EGFR protein and mRNA levels.
- Use of proteasome and lysosome inhibitors.
- Pulse-chase experiments with 35S-methionine.
- Analysis of clinical lung adenocarcinoma samples.
Main Results:
- MIIP overexpression decreased EGFR protein levels without affecting EGFR mRNA, indicating post-transcriptional regulation.
- EGFR degradation was mediated by both proteasomal and lysosomal pathways, involving ER and endocytic trafficking.
- MIIP-induced EGFR downregulation inhibited Ras/MEK signaling, leading to reduced cell proliferation.
- A negative correlation between MIIP and EGFR protein expression was observed in lung adenocarcinoma.
- High MIIP expression predicted better survival in Stage IA-IIIA lung adenocarcinoma patients.
Conclusions:
- MIIP inhibits lung cancer cell proliferation by promoting EGFR protein degradation through both proteasomal and lysosomal pathways.
- MIIP serves as a potential prognostic biomarker for improved survival in lung adenocarcinoma patients.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

